Table 3.
Treatment decision before and after 89Zr-trastuzumab PET
| Treatment planned before 89Zr-trastuzumab PET | Treatment given after 89Zr-trastuzumab PET | ||
|---|---|---|---|
| Anti-HER2 (± chemo) | No anti-HER2 (other systemic treatment) | No systemic treatment | |
| • Anti-HER2 (± chemo) | 5 | 2 | 0 |
| • No anti-HER2 (other systemic treatment) | 2 | 4 | 0 |
| • No systemic treatment | 1 | 0 | 3 |
| • Unsure on systemic treatment choice/dependent on additional test | 2 | 1 | 0 |